company background image
LH logo

Labcorp Holdings NYSE:LH Stock Report

Last Price

US$228.61

Market Cap

US$19.0b

7D

-1.5%

1Y

2.0%

Updated

20 Dec, 2024

Data

Company Financials +

My Notes

Capture your thoughts, links and company narrative

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$262.88
FV
13.0% undervalued intrinsic discount
4.77%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
2 days ago author updated this narrative

Labcorp Holdings Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Labcorp Holdings
Historical stock prices
Current Share PriceUS$228.61
52 Week HighUS$247.99
52 Week LowUS$191.97
Beta1.04
1 Month Change-3.88%
3 Month Change2.88%
1 Year Change2.05%
3 Year Change-24.28%
5 Year Change35.00%
Change since IPO837.89%

Recent News & Updates

Recent updates

Labcorp Holdings Inc.'s (NYSE:LH) Price In Tune With Earnings

Nov 12
Labcorp Holdings Inc.'s (NYSE:LH) Price In Tune With Earnings

Is Labcorp Holdings (NYSE:LH) Using Too Much Debt?

Oct 19
Is Labcorp Holdings (NYSE:LH) Using Too Much Debt?

When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Sep 12
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Laboratory Corporation: Difficult To Eye Long-Term Compounding Ability

Sep 11

Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)

Jul 20
Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)

Laboratory Corporation: Limited Upside Visibility, Reiterate Hold

Jun 21

When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Jun 13
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?

Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year

May 08
Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year

Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72

Apr 30
Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72

Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72

Apr 15
Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72

Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark

Apr 06
Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark

Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear

Apr 01

Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72

Feb 25
Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72

We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings

Feb 22
We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings

An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued

Feb 21
An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued

Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72

Jan 31
Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72

Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly

Jan 30
Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly

Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72

Jan 15
Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72

Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio

Jan 05
Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio

Laboratory Corporation: Multiple Updates, Same Investment Conclusion

Dec 02

Laboratory Corp.: Rate On Capital Deployed Contracting, Hold

Sep 14

Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea

Jul 05

Laboratory Corporation: Predictability Of Cash Flows Less Visible

Jun 21

Shareholder Returns

LHUS HealthcareUS Market
7D-1.5%-5.0%-3.5%
1Y2.0%-11.4%22.1%

Return vs Industry: LH exceeded the US Healthcare industry which returned -11.4% over the past year.

Return vs Market: LH underperformed the US Market which returned 22.1% over the past year.

Price Volatility

Is LH's price volatile compared to industry and market?
LH volatility
LH Average Weekly Movement2.9%
Healthcare Industry Average Movement7.6%
Market Average Movement6.3%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: LH has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: LH's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199561,975Adam Schechterwww.labcorp.com

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests.

Labcorp Holdings Inc. Fundamentals Summary

How do Labcorp Holdings's earnings and revenue compare to its market cap?
LH fundamental statistics
Market capUS$18.98b
Earnings (TTM)US$435.50m
Revenue (TTM)US$12.71b

43.9x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LH income statement (TTM)
RevenueUS$12.71b
Cost of RevenueUS$9.16b
Gross ProfitUS$3.55b
Other ExpensesUS$3.11b
EarningsUS$435.50m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)5.21
Gross Margin27.92%
Net Profit Margin3.43%
Debt/Equity Ratio83.2%

How did LH perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

56%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 22:33
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Labcorp Holdings Inc. is covered by 48 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Brian Kemp DolliverAvondale Partners
Eric ColdwellBaird